PMID: 8966377May 1, 1996Paper

Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency

Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
J M GuízarC Kornhauser

Abstract

To study the results of a single dose weekly treatment with subcutaneous recombinant human erythropoietin in the anemia of children with end stage renal failure patients. We studied 19 patients 6 to 17 years old with end-stage renal failure under ambulatory peritoneal dialysis at the Centro Médico Nacional of the city of León, State of Guanajuato. All had required an average of 2.8 red blood cell transfusions during the previous 18.2 months. The criteria for inclusion were: severe normocytic normochromic anemia (Hct < 20%) without infectious or systemic illness, blood pressure under the 97th percentile for their age, normal hepatic function, and absence of convulsive crisis. The erythropoietin was subcutaneously administered once a week at a dose of 130 +/- 15 U/kg of body weight (SD). All patients received minimal daily iron and folic acid requirements. The initial average values for hemoglobin and hematocrit were 6.6 +/- 0.9 g/dL and 20.6 +/- 3.3% respectively. They increased to 9.4 +/- 0.9 g/dL and 28.8 +/- 2.5% after 12 weeks of treatment (p < 0.05). The patients did not receive blood transfusions during the study period and their blood pressure remained unchanged. The subcutaneous administration of erythropoietin in our st...Continue Reading

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
F Valderrábano
© 2021 Meta ULC. All rights reserved